Related Experiment Videos
1,25-Dihydroxycholecalciferol enhances butyrate-induced p21(Waf1/Cip1) expression
T Gaschott1, A Wächtershäuser, D Steinhilber
1Second Department of Medicine, Johann Wolfgang Goethe University, Frankfurt/Main, Germany.
Biochemical and Biophysical Research Communications
|April 27, 2001
Summary
Butyrate, a colon cancer cell differentiator, enhances vitamin D receptor (VDR) expression. This synergy selectively amplifies p21(Waf1/Cip1) expression, a key cell cycle regulator, in colon cancer cells.
Area of Science:
- Molecular biology
- Cell biology
- Gastroenterology
Background:
- Butyrate and tributyrin promote colon cancer cell differentiation.
- p21(Waf1/Cip1) and p27(Kip1) are crucial negative regulators of cell cycle progression and differentiation.
- The role of butyrate in modulating these factors in human colon cancer cells requires further investigation.
Purpose of the Study:
- To investigate the effects of butyrate on differentiation, VDR, p21(Waf1/Cip1), and p27(Kip1) expression in Caco-2 human colon cancer cells.
- To determine the synergistic effects of butyrate and 1,25-dihydroxycholecalciferol on these cellular processes.
Main Methods:
- Treatment of Caco-2 cells with butyrate and/or 1,25-dihydroxycholecalciferol.
- Assessment of cell differentiation markers.
- Quantification of VDR, p21(Waf1/Cip1), and p27(Kip1) expression levels.
Main Results:
- Butyrate induced differentiation in Caco-2 cells, an effect potentiated by 1,25-dihydroxycholecalciferol.
- The synergistic effect was attributed to butyrate-induced upregulation of the vitamin D receptor (VDR).
- Both agents increased p21(Waf1/Cip1) and p27(Kip1) expression, but combined treatment synergistically amplified p21(Waf1/Cip1) only.
Conclusions:
- Butyrate selectively upregulates VDR expression in Caco-2 cells.
- Butyrate enhances colon cancer cell differentiation, partly through VDR-mediated mechanisms.
- The findings suggest a specific role for butyrate in modulating p21(Waf1/Cip1) expression via VDR in colon cancer.